This is a limited company view. Sign up for a Free Trial to see everything.

Kineta, a biotechnology company, aims at developing leading edge therapeutics in autoimmune disease, viral disease and chronic pain areas.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Seattle

Founded

2008

Employees

40

Stage

Exited

Total funding

$9M

Last funding

2 years ago

Acquisitions

0

Growth score

92

Mindshare score

94

Scoring

Deals

Undisclosed Amount Venture

National Institute of Allergy and Infectious Diseases

Jul 26, 2016

$1.3M Venture

Jan 15, 2015

$760.5K Venture

Oct 8, 2013

$5.8M Venture

Aug 8, 2012

$942.5K Venture

Jan 7, 2010

Employee Growth

Use Kineta's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Kineta's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Chief Executive Officer
Director of Biodefense Initiatives
Director of Discovery Research
Sr. Manager of Preclinical Operations and Translational Development
Group Lead
Director and Head of Immunology
Senior Research Associate
Principal Research Associate
Senior Accountant
Research Associate II
Principal Research Associate
Sr. Research Associate, Translational Development/Analytical
Corporate Paralegal
Research Associate II
Principal Scientist - Discovery Research/Virology
Consultant
Senior Scientist

Similar Companies

Tekmira Pharmaceuticals

Public|121 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes